1/n
Attention, deprescribers 💊
What are 10 critical #deprescribing articles you should probably know about?
@wadddee and I have asked that very question and compiled a list of our top 10 #deprescribing articles essential for all deprescribers! 👇
Attention, deprescribers 💊
What are 10 critical #deprescribing articles you should probably know about?
@wadddee and I have asked that very question and compiled a list of our top 10 #deprescribing articles essential for all deprescribers! 👇
2/n
We chose 10 articles (out of many candidates!) that, in our opinion, together provide an overview of the field of #deprescribing. This covers the mindset and complexity of deprescribing, the development and testing of new interventions, and perspectives on future research.
We chose 10 articles (out of many candidates!) that, in our opinion, together provide an overview of the field of #deprescribing. This covers the mindset and complexity of deprescribing, the development and testing of new interventions, and perspectives on future research.
3/n
We described the selections in more detail in a blog post at the @Deprescribing Blog 👉 deprescribing.org/news/10-import…
Here we will BRIEFLY highlight each of the articles!
Okay, here we go! 👇
We described the selections in more detail in a blog post at the @Deprescribing Blog 👉 deprescribing.org/news/10-import…
Here we will BRIEFLY highlight each of the articles!
Okay, here we go! 👇
4/n
#1: In our first selection, @DrHollyHolmes et al. introduces the very core concepts integral to #deprescribing: life expectancy vs time to benefit, goals of care, and treatment targets.
Simply a must read for all deprescribers!
jamanetwork.com/journals/jamai…
#1: In our first selection, @DrHollyHolmes et al. introduces the very core concepts integral to #deprescribing: life expectancy vs time to benefit, goals of care, and treatment targets.
Simply a must read for all deprescribers!
jamanetwork.com/journals/jamai…
5/n
#2: How is it that people end up on so many medications? 💊
This is nicely demonstrated by @DanielOkeowo2 et al. in this paper applying treatment guidelines to a hypothetical older patient with multimorbidity and life-limiting illness!
pubmed.ncbi.nlm.nih.gov/30479737/
#2: How is it that people end up on so many medications? 💊
This is nicely demonstrated by @DanielOkeowo2 et al. in this paper applying treatment guidelines to a hypothetical older patient with multimorbidity and life-limiting illness!
pubmed.ncbi.nlm.nih.gov/30479737/
6/n
#3: #Deprescribing may not be as easy to implement in clinical practice as we would hope. Why is that?
With the deprescribing rainbow, @adamtodd138 et al. highlights the myriad considerations that go into deprescribing at the patient level 🌈
bmcgeriatr.biomedcentral.com/articles/10.11…
#3: #Deprescribing may not be as easy to implement in clinical practice as we would hope. Why is that?
With the deprescribing rainbow, @adamtodd138 et al. highlights the myriad considerations that go into deprescribing at the patient level 🌈
bmcgeriatr.biomedcentral.com/articles/10.11…
7/n
#4: Patients might have very different preferences when it comes to decision-making about #deprescribing.
Here, @KristieWeir et al. clearly demonstrates the importance of taking individual patient preferences and context into account!
academic.oup.com/psychsocgeront…
#4: Patients might have very different preferences when it comes to decision-making about #deprescribing.
Here, @KristieWeir et al. clearly demonstrates the importance of taking individual patient preferences and context into account!
academic.oup.com/psychsocgeront…
8/n
#5: In our fifth selection, @mouna_sawan et al. provides a higher-level view of how #deprescribing fits into healthcare systems, offering critical insight into how to increase uptake in clinical practice from a health system perspective.
tandfonline.com/doi/full/10.10…
#5: In our fifth selection, @mouna_sawan et al. provides a higher-level view of how #deprescribing fits into healthcare systems, offering critical insight into how to increase uptake in clinical practice from a health system perspective.
tandfonline.com/doi/full/10.10…
9/n
#6: What about all of the #deprescribing tools out there? 🛠️
Here, @MikeSteinman and Fick nicely frames the pros/cons of using explicit tools such as the Beers or STOPP criteria, which continue to be highly used despite important limitations.
agsjournals.onlinelibrary.wiley.com/doi/full/10.11…
#6: What about all of the #deprescribing tools out there? 🛠️
Here, @MikeSteinman and Fick nicely frames the pros/cons of using explicit tools such as the Beers or STOPP criteria, which continue to be highly used despite important limitations.
agsjournals.onlinelibrary.wiley.com/doi/full/10.11…
10/n
#7: How to get updated on what existing #deprescribing interventions have achieved (or been trying to achieve)?
Isenor et al. takes a closer look at this in this review and highlights important gaps in these interventions!
sciencedirect.com/science/articl…
#7: How to get updated on what existing #deprescribing interventions have achieved (or been trying to achieve)?
Isenor et al. takes a closer look at this in this review and highlights important gaps in these interventions!
sciencedirect.com/science/articl…
11/n
#8: Various patient education materials for #deprescribing have been developed. However, we have room for improvement in this area, as there are important limitations to many of these tools, as nicely demonstrated in this review by Fajardo et al.
bpspubs.onlinelibrary.wiley.com/doi/full/10.11…
#8: Various patient education materials for #deprescribing have been developed. However, we have room for improvement in this area, as there are important limitations to many of these tools, as nicely demonstrated in this review by Fajardo et al.
bpspubs.onlinelibrary.wiley.com/doi/full/10.11…
12/n
#9: In our next selection, @KatharinaJungo et al. goes beyond the traditional barriers/facilitators research to look at what actually influences physician #deprescribing decisions in clinical practice.
bmcgeriatr.biomedcentral.com/articles/10.11…
#9: In our next selection, @KatharinaJungo et al. goes beyond the traditional barriers/facilitators research to look at what actually influences physician #deprescribing decisions in clinical practice.
bmcgeriatr.biomedcentral.com/articles/10.11…
13/n
#10: Our final selection is a call to action for all of us!
Patient-centered and clinically important outcomes are important to capture in #deprescribing research, and we have a long way to go as demonstrated by Aubert et al.
agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…
#10: Our final selection is a call to action for all of us!
Patient-centered and clinically important outcomes are important to capture in #deprescribing research, and we have a long way to go as demonstrated by Aubert et al.
agsjournals.onlinelibrary.wiley.com/doi/10.1111/jg…
/end
Have we missed any important papers? Do you have opinions about our selections or omissions?
Please let us know – we will then follow up with a complete list of recommended #deprescribing articles for use of all deprescribers out there! 💊🥳
@wadddee and @CarinaLundby
Have we missed any important papers? Do you have opinions about our selections or omissions?
Please let us know – we will then follow up with a complete list of recommended #deprescribing articles for use of all deprescribers out there! 💊🥳
@wadddee and @CarinaLundby
• • •
Missing some Tweet in this thread? You can try to
force a refresh
